ESCRS - Avedro presents novel Boost Epi-On corneal CXL data ;

Avedro presents novel Boost Epi-On corneal CXL data

Non-invasive corneal CXL procedure does not require removal of the epithelium

Avedro presents novel Boost Epi-On corneal CXL data
Priscilla Lynch
Priscilla Lynch
Published: Monday, September 16, 2019
AVEDRO showcased early data on its novel Boost Epi-On cross-linking (CXL) technology for the treatment of keratoconus during an educational session at the 37th Congress of the ESCRS yesterday. Presentations highlighted the positive early clinical experiences of several clinicians from different countries who have evaluated Boost Epi-On CXL, a non-invasive corneal CXL procedure that does not require removal of the epithelium. The latest-generation technology addresses the limitations of prior epi-on procedures through the addition of supplemental oxygen. This drives oxygen diffusion across the epithelium to enhance CXL, better stabilising and strengthening the cornea and ultimately halting or slowing keratoconus progression, yesterday’s educational session heard. The procedure is thus easier, with less postoperative ocular discomfort and a faster recovery time. It is also safer with less risk of complications and preserves corneal thickness as well as improving visual acuity, speakers said. Speaking to EuroTimes, Avedro CEO Reza Zadno PhD noted that keratoconus is a disease that particularly impacts young people, “and treating and halting its progression leads to a major quality of life improvement for these patients”.
Latest Articles
Committing to a More Equitable Ophthalmology

Charity Committee enhances ESCRS’s reputation as a socially responsible society.

Read more...

Virtual Community Unites Ukrainian Eye Specialists

Microlearning platform proves vital to saving eyes and lives in areas of conflict.

Read more...

ESCRS Survey Shifts Industry Dial

Annual survey reveals trends and issues regarding the digital OR.

Read more...

Always Measure the Epithelium!

Epithelium thickness mapping key to better refractive outcomes.

Read more...

Supplement: Bringing the Cataract Workflow into the Future with Integrated OR Technology

Read more...

Overcoming Barriers to Presbyopic IOL Uptake

Improving technology, patient and doctor awareness, and reimbursement are keys.

Read more...

Battling Bias in Science

Hidden biases in science impact careers and patient care.

Read more...

Training in the Digital Era

AI-powered, cloud-based system can effectively improve traineeship, save time, and increase performance.

Read more...

Treating Myopia, Inside and Outside

Lifestyle changes and ophthalmic interventions play a role in treating paediatric myopia.

Read more...

The Promises and Pitfalls of AI

While AI shows potential in healthcare, experts agree it requires bias mitigation and human oversight.

Read more...